Showing results (181-190 of 232) with videos related to

Sort By:
Pageof 24
Frontiers in Endocrinology|July 6, 2023
<i>Post hoc</i> analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of respondersValeria Sordi, Paolo Monti, Vito Lampasona, et al.
Diabetes Technology & Therapeutics|April 27, 2013
Evaluation of glycemic variability in well-controlled type 2 diabetes mellitusSuk Chon, Yun Jung Lee, Gemma Fraterrigo, et al.
Hormones (Athens, Greece)|August 8, 2018
A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twinsAndrea Palermo, Ettore Capoluongo, Rossella Del Toro, et al.
Diabetes Care|August 31, 2016
Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11Nanette C Schloot, Minh N Pham, Mohammed I Hawa, et al.
Clinical Endocrinology|November 18, 2014
Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activityAndrea Palermo, Rocky Strollo, Ernesto Maddaloni, et al.
Thyroid : Official Journal of the American Thyroid Association|February 15, 2020
Laser Ablation Versus Radiofrequency Ablation for Benign Non-Functioning Thyroid Nodules: Six-Month Results of a Randomized, Parallel, Open-Label, Trial (LARA Trial)Roberto Cesareo, Claudio Maurizio Pacella, Valerio Pasqualini, et al.
Diabetes/Metabolism Research and Reviews|December 28, 2020
The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DMEric Renard, Hiroshi Ikegami, André Gustavo Daher Vianna, et al.
Diabetes|December 25, 2003
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001Jerry P Palmer, G Alexander Fleming, Carla J Greenbaum, et al.
Bone|May 7, 2019
Risk factors for fragility fractures in type 1 diabetesGiulia Leanza, Ernesto Maddaloni, Dario Pitocco, et al.
Diabetes/Metabolism Research and Reviews|May 11, 2011
Blue eyes as a risk factor for type 1 diabetesEnrico Di Stasio, Daria Maggi, Enzo Berardesca, et al.
Pageof 24